TUBB4A-associated leukodystrophy
Dr Dan Williams, CEO and Co-Founder of new biotech business SynaptixBio, discusses how the search is on to find the first treatment for...
TUBB4A-associated leukodystrophy
Business digest C&I Issue 11, 2021
New biotech firm launched to develop ‘revolutionary’ treatment for one of world’s rarest diseases
Oxford Biotech Firm Launches To Tackle Rare Disease – Insider Limited
Oxford biotech firm launches to tackle rare disease
SynaptixBio launched with singular focus
Danish biotech profile is helping to establish its fourth company abroad
Synaptixbio sets off on quest to find therapy for rare CNS disease
Oxford biotech firm SynaptixBio launched to develop ‘revolutionary’ treatment
Biotech to develop treatment for neurodegenerative disease
This week in drug discovery (18-22 October)
SynaptixBio Formed to Tackle One of the World’s Rarest Diseases